Stable RAGE-heparan sulfate complexes are essential for signal transduction

ACS Chemical Biology

Volumn 8, Issue 7, 2013, Pages 1611-1620

  Xu, Ding ^a   Young, Jeffrey H ^a   Krahn, Juno M ^b   Song, Danyin ^a   Corbett, Kevin D ^a   Chazin, Walter J ^c   Pedersen, Lars C ^b   Esko, Jeffrey D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; DIMER; EPITOPE; HEPARAN SULFATE; MONOCLONAL ANTIBODY; MONOMER;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HYDROPHOBICITY; MUTAGENESIS; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STATIC ELECTRICITY; STOICHIOMETRY; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

ANTIGENS, NEOPLASM; COORDINATION COMPLEXES; DIMERIZATION; DRUG STABILITY; ENDOTHELIAL CELLS; HEPARITIN SULFATE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, MOLECULAR; SIGNAL TRANSDUCTION; X-RAY DIFFRACTION;

EID: 84880555698     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb4001553     Document Type: Article

References (37)

1. Brownlee, M., Cerami, A., and Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N. Engl. J. Med. 318, 1315-1321
2. Basta, G. (2008) Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications Atherosclerosis 196, 9-21
3. Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., and Coyle, A. J. (2010) HMGB1 and RAGE in inflammation and cancer Annu. Rev. Immunol. 28, 367-388
4. Liliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Grone, H. J., Kurschus, F. C., Schmidt, A. M., Yan, S. D., Martin, E., Schleicher, E., Stern, D. M., Hammerling, G. G., Nawroth, P. P., and Arnold, B. (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J. Clin. Invest. 113, 1641-1650
5. Muhammad, S., Barakat, W., Stoyanov, S., Murikinati, S., Yang, H., Tracey, K. J., Bendszus, M., Rossetti, G., Nawroth, P. P., Bierhaus, A., and Schwaninger, M. (2008) The HMGB1 receptor RAGE mediates ischemic brain damage J. Neurosci. 28, 12023-12031
6. Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Jr., Chow, W. S., Stern, D., and Schmidt, A. M. (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Nat. Med. 4, 1025-1031
7. Yan, S. F., Ramasamy, R., and Schmidt, A. M. (2010) The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature Circ. Res. 106, 842-853
8. Yan, S. S., Wu, Z. Y., Zhang, H. P., Furtado, G., Chen, X., Yan, S. F., Schmidt, A. M., Brown, C., Stern, A., LaFaille, J., Chess, L., Stern, D. M., and Jiang, H. (2003) Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system Nat. Med. 9, 287-293
9. Dattilo, B. M., Fritz, G., Leclerc, E., Kooi, C. W., Heizmann, C. W., and Chazin, W. J. (2007) The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units Biochemistry 46, 6957-6970
10. Koch, M., Chitayat, S., Dattilo, B. M., Schiefner, A., Diez, J., Chazin, W. J., and Fritz, G. (2010) Structural basis for ligand recognition and activation of RAGE Structure 18, 1342-1352
11. Leclerc, E., Fritz, G., Weibel, M., Heizmann, C. W., and Galichet, A. (2007) S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains J. Biol. Chem. 282, 31317-31331
12. Ostendorp, T., Leclerc, E., Galichet, A., Koch, M., Demling, N., Weigle, B., Heizmann, C. W., Kroneck, P. M., and Fritz, G. (2007) Structural and functional insights into RAGE activation by multimeric S100B EMBO J. 26, 3868-3878
13. Xue, J., Rai, V., Singer, D., Chabierski, S., Xie, J., Reverdatto, S., Burz, D. S., Schmidt, A. M., Hoffmann, R., and Shekhtman, A. (2011) Advanced glycation end product recognition by the receptor for AGEs Structure 19, 722-732
14. Sakaguchi, M., Murata, H., Yamamoto, K., Ono, T., Sakaguchi, Y., Motoyama, A., Hibino, T., Kataoka, K., and Huh, N. H. (2011) TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding PLoS One 6, e23132
15. Hudson, B. I., Kalea, A. Z., Del Mar Arriero, M., Harja, E., Boulanger, E., D'Agati, V., and Schmidt, A. M. (2008) Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42 J. Biol. Chem. 283, 34457-34468
16. Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., and Kasaoka, T. (2003) The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site FEBS Lett. 550, 107-113
17. Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D. S., and Shekhtman, A. (2008) Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE) J. Biol. Chem. 283, 27255-27269
18. Zong, H., Madden, A., Ward, M., Mooney, M. H., Elliott, C. T., and Stitt, A. W. (2010) Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction J. Biol. Chem. 285, 23137-23146
19. Sarkany, Z., Ikonen, T. P., Ferreira-da-Silva, F., Saraiva, M. J., Svergun, D., and Damas, A. M. (2011) Solution structure of the soluble receptor for advanced glycation end products (sRAGE) J. Biol. Chem. 286, 37525-37534
20. Xu, D., Young, J., Song, D., and Esko, J. D. (2011) Heparan sulfate is essential for High Mobility Group Protein 1 (HMGB1) signaling by the Receptor for Advanced Glycation End Products (RAGE) J. Biol. Chem. 286, 41736-41744
21. Goyette, J., Yan, W. X., Yamen, E., Chung, Y. M., Lim, S. Y., Hsu, K., Rahimi, F., Di Girolamo, N., Song, C., Jessup, W., Kockx, M., Bobryshev, Y. V., Ben Freedman, S., and Geczy, C. L. (2009) Pleiotropic roles of S100A12 in coronary atherosclerotic plaque formation and rupture J Immunol. 183, 593-603
22. Robinson, M. J., Tessier, P., Poulsom, R., and Hogg, N. (2002) The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells J. Biol. Chem. 277, 3658-3665
23. Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., Neurath, M. F., Slattery, T., Beach, D., McClary, J., Nagashima, M., Morser, J., Stern, D., and Schmidt, A. M. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97, 889-901
24. Rai, V., Toure, F., Chitayat, S., Pei, R., Song, F., Li, Q., Zhang, J., Rosario, R., Ramasamy, R., Chazin, W. J., and Schmidt, A. M. (2012) Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling J. Exp. Med. 209, 2339-2350
25. Park, H., Adsit, F. G., and Boyington, J. C. (2010) The 1.5 A crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding J. Biol. Chem. 285, 40762-40770
26. Janin, J., Bahadur, R. P., and Chakrabarti, P. (2008) Protein-protein interaction and quaternary structure Q. Rev. Biophys. 41, 133-180
27. Bernado, P. (2010) Effect of interdomain dynamics on the structure determination of modular proteins by small-angle scattering Eur. Biophys. J. 39, 769-780
28. Heller, W. T. (2005) Influence of multiple well defined conformations on small-angle scattering of proteins in solution Acta Crystallogr., Sect. D: Biol. Crystallogr. 61, 33-44
29. Mohammadi, M., Olsen, S. K., and Ibrahimi, O. A. (2005) Structural basis for fibroblast growth factor receptor activation Cytokine Growth Factor Rev. 16, 107-137
30. Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., Eliseenkova, A. V., Yeh, B. K., Yayon, A., Linhardt, R. J., and Mohammadi, M. (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization Mol. Cell 6, 743-750
31. Brozzo, M. S., Bjelic, S., Kisko, K., Schleier, T., Leppanen, V. M., Alitalo, K., Winkler, F. K., and Ballmer-Hofer, K. (2012) Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization Blood 119, 1781-1788
32. Xu, D., Fuster, M. M., Lawrence, R., and Esko, J. D. (2011) Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability J. Biol. Chem. 286, 737-745
33. Leahy, D. J. (2008) A molecular view of anti-ErbB monoclonal antibody therapy Cancer Cell 13, 291-293
34. Schmiedel, J., Blaukat, A., Li, S., Knochel, T., and Ferguson, K. M. (2008) Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization Cancer Cell 13, 365-373
35. Qing, J., Du, X., Chen, Y., Chan, P., Li, H., Wu, P., Marsters, S., Stawicki, S., Tien, J., Totpal, K., Ross, S., Stinson, S., Dornan, D., French, D., Wang, Q. R., Stephan, J. P., Wu, Y., Wiesmann, C., and Ashkenazi, A. (2009) Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice J. Clin. Invest. 119, 1216-1229
36. Zwart, P. H., Afonine, P. V., Grosse-Kunstleve, R. W., Hung, L. W., Ioerger, T. R., McCoy, A. J., McKee, E., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., Storoni, L. C., Terwilliger, T. C., and Adams, P. D. (2008) Automated structure solution with the PHENIX suite Methods Mol. Biol. 426, 419-435
37. Emsley, P. and Cowtan, K. (2004) Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 60, 2126-2132